Effectiveness of Frequent Point-of-Care Molecular COVID-19 Surveillance in a Rural Workplace: Nonrandomized Controlled Clinical Trial Among Miners.

Publication date: Jan 27, 2025

Numerous studies have assessed the risk of SARS-CoV-2 exposure and infection among health care workers during the pandemic. However, far fewer studies have investigated the impact of SARS-CoV-2 on essential workers in other sectors. Moreover, guidance for maintaining a safely operating workplace in sectors outside of health care remains limited. Workplace surveillance has been recommended by the Centers for Disease Control and Prevention, but few studies have examined the feasibility or effectiveness of this approach. The objective of this study was to investigate the feasibility and effectiveness of using frequent point-of-care molecular workplace surveillance as an intervention strategy to prevent the spread of SARS-CoV-2 at essential rural workplaces (mining sites) where physical distancing, remote work, and flexible schedules are not possible. In this nonrandomized controlled clinical trial conducted from February 2021, to March 2022, 169 miners in New Mexico (intervention cohort) and 61 miners in Wyoming (control cohort) were enrolled. Investigators performed point-of-care rapid antigen testing on midnasal swabs (NSs) self-collected by intervention miners. Our first outcome was the intervention acceptance rate in the intervention cohort. Our second outcome was the rate of cumulative postbaseline seropositivity to SARS-CoV-2 nucleocapsid protein, which was analyzed in the intervention cohort and compared to the control cohort between baseline and 12 months. The diagnostic accuracy of detecting SARS-CoV-2 using rapid antigen testing on NSs was compared to laboratory-based reverse transcriptase polymerase chain reaction (RT-PCR) on nasopharyngeal swabs (NPSs) in a subset of 68 samples. Our intervention had a mean acceptance rate of 96. 4% (11,413/11,842). The intervention miners exhibited a lower cumulative postbaseline incident seropositivity at 12 months compared to control miners (14/97, 14% vs 17/45, 38%; P=. 002). Analysis of SARS-CoV-2 antigen detection in self-administered NSs revealed 100% sensitivity and specificity compared to laboratory-based RT-PCR testing on NPSs. Our findings establish frequent point-of-care molecular workplace COVID-19 surveillance as a feasible option for keeping essential rural workplaces open and preventing SARS-CoV-2 spread. These findings extend beyond this study, providing valuable insights for designing interventions to maintain employees’ safety at other essential workplaces during an infectious disease outbreak.

Open Access PDF

Concepts Keywords
Mexico Adult
Pandemic antigen testing
Rural coronavirus
Workplaces COVID-19
COVID-19
Female
Humans
infectious disease
Male
Middle Aged
midnasal swabs
Miners
miners
New Mexico
pandemic
point-of-care
Point-of-Care Systems
public health
Rural Population
rural workplace
SARS-CoV-2
SARS-CoV-2
seroprevalence
surveillance
Workplace

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease IDO intervention
disease MESH infectious disease
pathway REACTOME Infectious disease
drug DRUGBANK Methylphenidate
disease IDO nucleic acid
drug DRUGBANK Gold
disease MESH complications
disease IDO site
disease IDO symptom
disease IDO history
disease IDO process
disease IDO blood
disease MESH Emergency
disease IDO protein
disease IDO quality
disease MESH viral load
drug DRUGBANK Sodium lauryl sulfate
disease MESH educational status
disease IDO host
disease IDO susceptibility
disease MESH asthma
pathway KEGG Asthma
disease MESH chronic obstructive pulmonary disease
disease MESH lung diseases
disease MESH hypertension
disease MESH depression
disease MESH comorbidity
disease IDO assay

Original Article

(Visited 1 times, 1 visits today)